Belite Bio (Belite Bio) Accumulated Depreciation : $0.00 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Belite Bio Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Belite Bio's quarterly accumulated depreciation increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($-0.18 Mil) but then stayed the same from Dec. 2023 ($-0.18 Mil) to Mar. 2024 ($0.00 Mil).

Belite Bio's annual accumulated depreciation increased from Dec. 2021 ($-0.05 Mil) to Dec. 2022 ($-0.09 Mil) and increased from Dec. 2022 ($-0.09 Mil) to Dec. 2023 ($-0.18 Mil).

Belite Bio Accumulated Depreciation Historical Data

The historical data trend for Belite Bio's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belite Bio Accumulated Depreciation Chart

Belite Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

-0.05

-0.09

-0.18

Belite Bio Quarterly Data
	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial							-	-	-	-0.18	-

Belite Bio Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Belite Bio Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Belite Bio's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Belite Bio (Belite Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Belite Bio Inc (NAS:BLTE) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

D01:Germany

Address

12750 High Bluff Drive, Suite 475, San Diego, CA, USA, 92130

Website

https://www.belitebio.com

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.